Search Results

There are 12778 results for: content related to: Women Receiving News of a Family BRCA1/2 Mutation: Messages of Fear and Empowerment

  1. Skin cancer risk in BRCA1/2 mutation carriers

    British Journal of Dermatology

    Volume 172, Issue 6, June 2015, Pages: 1498–1506, P.V. Gumaste, L.A. Penn, R.M. Cymerman, T. Kirchhoff, D. Polsky and B. McLellan

    Version of Record online : 29 APR 2015, DOI: 10.1111/bjd.13626

  2. You have free access to this content
    Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel

    Cancer

    Volume 121, Issue 1, January 1, 2015, Pages: 25–33, Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E. Garber, Christina Herold, Leif Ellisen, Jill Krejdovsky, Kim DeLeonardis, Kristin Sedgwick, Kathleen Soltis, Benjamin Roa, Richard J. Wenstrup and Anne-Renee Hartman

    Version of Record online : 3 SEP 2014, DOI: 10.1002/cncr.29010

  3. You have free access to this content
    The molecular pathogenesis of hereditary ovarian carcinoma

    Cancer

    Volume 116, Issue 22, 15 November 2010, Pages: 5261–5271, Barbara M. Norquist, Rochelle L. Garcia, Kimberly H. Allison, Chris H. Jokinen, Lauren E. Kernochan, Catherine C. Pizzi, Bethany J. Barrow, Barbara A. Goff and Elizabeth M. Swisher

    Version of Record online : 3 NOV 2010, DOI: 10.1002/cncr.25439

  4. All in the family: Evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results

    American Journal of Medical Genetics

    Volume 107, Issue 2, 15 January 2002, Pages: 143–150, Chanita Hughes, Caryn Lerman, Marc Schwartz, Beth N. Peshkin, Lari Wenzel, Steven Narod, Camille Corio, Kenneth P. Tercyak, Danielle Hanna, Claudine Isaacs and David Main

    Version of Record online : 28 NOV 2001, DOI: 10.1002/ajmg.10110

  5. You have free access to this content
    BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts

    Cancer

    Volume 120, Issue 13, 1 July 2014, Pages: 1960–1967, Aimee L. Lucas, Laura E. Frado, Caroline Hwang, Sheila Kumar, Lauren G. Khanna, Elana J. Levinson, John A. Chabot, Wendy K. Chung and Harold Frucht

    Version of Record online : 15 APR 2014, DOI: 10.1002/cncr.28662

  6. You have free access to this content
    Comparison of age at natural menopause in BRCA1/2 mutation carriers with a non–clinic-based sample of women in northern California

    Cancer

    Volume 119, Issue 9, 1 May 2013, Pages: 1652–1659, Wayne T. Lin, Mary Beattie, Lee-may Chen, Kutluk Oktay, Sybil L. Crawford, Ellen B. Gold, Marcelle Cedars and Mitchell Rosen

    Version of Record online : 29 JAN 2013, DOI: 10.1002/cncr.27952

  7. You have full text access to this Open Access content
    Secondary mutations of BRCA1/2 and drug resistance

    Cancer Science

    Volume 102, Issue 4, April 2011, Pages: 663–669, Kiranjit K. Dhillon, Elizabeth M. Swisher and Toshiyasu Taniguchi

    Version of Record online : 30 JAN 2011, DOI: 10.1111/j.1349-7006.2010.01840.x

  8. You have free access to this content
    MicroRNA expression signatures for the prediction of BRCA1/2 mutation-associated hereditary breast cancer in paraffin-embedded formalin-fixed breast tumors

    International Journal of Cancer

    Volume 136, Issue 3, 1 February 2015, Pages: 593–602, Miljana Tanic, Kira Yanowski, Gonzalo Gómez-López, María Socorro Rodriguez-Pinilla, Iván Marquez-Rodas, Ana Osorio, David G. Pisano, Beatriz Martinez-Delgado and Javier Benítez

    Version of Record online : 19 JUN 2014, DOI: 10.1002/ijc.29021

  9. You have free access to this content
    Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study

    Cancer

    Volume 119, Issue 20, 15 October 2013, Pages: 3596–3603, Anne Marie McCarthy, Mirar Bristol, Tracey Fredricks, Lache Wilkins, Irene Roelfsema, Kaijun Liao, Judy A. Shea, Peter Groeneveld, Susan M. Domchek and Katrina Armstrong

    Version of Record online : 16 JUL 2013, DOI: 10.1002/cncr.28268

  10. You have free access to this content
    Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: A national cohort study

    International Journal of Cancer

    Volume 135, Issue 12, 15 December 2014, Pages: 2940–2949, Sepideh Saadatmand, Janet R. Vos, Maartje J. Hooning, Jan C. Oosterwijk, Linetta B. Koppert, Geertruida H. de Bock, Margreet G. Ausems, Christi J. van Asperen, Cora M. Aalfs, Encarna B. Gómez Garcia, Hanne Meijers-Heijboer, Nicoline Hoogerbrugge, Marianne Piek, Caroline Seynaeve, Cornelis Verhoef, Matti Rookus, Madeleine M. Tilanus-Linthorst and the Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON)

    Version of Record online : 20 MAY 2014, DOI: 10.1002/ijc.28941

  11. Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer

    British Journal of Surgery

    Volume 93, Issue 8, August 2006, Pages: 961–968, M. M. A. Tilanus-Linthorst, C. Alves, C. Seynaeve, M. B. E. Menke-Pluymers, A. M. M. Eggermont and C. T. M. Brekelmans

    Version of Record online : 6 JUN 2006, DOI: 10.1002/bjs.5344

  12. Young adult daughters of BRCA1/2 positive mothers: What do they know about hereditary cancer and how much do they worry?

    Psycho-Oncology

    Volume 22, Issue 9, September 2013, Pages: 2024–2031, Andrea F. Patenaude, Nadine Tung, Paula D. Ryan, Leif W. Ellisen, Larissa Hewitt, Katherine A. Schneider, Kenneth P. Tercyak, Julie Aldridge and Judy E. Garber

    Version of Record online : 18 FEB 2013, DOI: 10.1002/pon.3257

  13. BRCA1/2 testing: uptake, phenocopies, and strategies to improve detection rates in initially negative families

    Clinical Genetics

    Volume 82, Issue 5, November 2012, Pages: 478–483, C Fischer, C Engel, C Sutter, S Zachariae, R Schmutzler, A Meindl, S Heidemann, T Grimm, TO Goecke, I Debatin, D Horn, P Wieacker, D Gadzicki, K Becker, D Schäfer, F Stock, T Voigtländer and on behalf of the German Consortium for Hereditary Breast and Ovarian Cancer

    Version of Record online : 19 OCT 2011, DOI: 10.1111/j.1399-0004.2011.01788.x

  14. Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations

    Histopathology

    Volume 57, Issue 6, December 2010, Pages: 877–884, Gunda Pristauz, Edgar Petru, Elvira Stacher, Jochen B Geigl, Thomas Schwarzbraun, Oleksiy Tsybrovskyy, Raimund Winter and Farid Moinfar

    Version of Record online : 17 DEC 2010, DOI: 10.1111/j.1365-2559.2010.03724.x

  15. Single-nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent

    Molecular Carcinogenesis

    Volume 49, Issue 6, June 2010, Pages: 545–555, Ronit I. Yarden, Eitan Friedman, Sally Metsuyanim, Tzvia Olender, Edna Ben-Asher and Moshe Z. Papa

    Version of Record online : 19 MAR 2010, DOI: 10.1002/mc.20618

  16. Familial concordance of breast cancer pathology as an indicator of genotype in multiple-case families

    Genes, Chromosomes and Cancer

    Volume 49, Issue 12, December 2010, Pages: 1082–1094, Rosemary L. Balleine, Pamela J. Provan, Gulietta M. Pupo, Nirmala Pathmanathan, Margaret Cummings, Gelareh Farshid, Elizabeth L. Salisbury, A. Michael Bilous, Karen Byth and Graham J. Mann

    Version of Record online : 2 SEP 2010, DOI: 10.1002/gcc.20816

  17. Impact of a paternal origin of germline BRCA1/2 mutations on the age at breast and ovarian cancer diagnosis in a Southern Swedish cohort

    Genes, Chromosomes and Cancer

    Volume 54, Issue 1, January 2015, Pages: 39–50, Carolina Ellberg, Helena Jernström, Per Broberg, Åke Borg and Håkan Olsson

    Version of Record online : 23 SEP 2014, DOI: 10.1002/gcc.22217

  18. You have full text access to this OnlineOpen article
    Clinical significance of large rearrangements in BRCA1 and BRCA2

    Cancer

    Volume 118, Issue 21, 1 November 2012, Pages: 5210–5216, Thaddeus Judkins, Eric Rosenthal, Christopher Arnell, Lynn Anne Burbidge, Wade Geary, Toby Barrus, Jeremy Schoenberger, Jeffrey Trost, Richard J. Wenstrup and Benjamin B. Roa

    Version of Record online : 27 APR 2012, DOI: 10.1002/cncr.27556

  19. Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals – correlation with clinicopathological data

    Clinical Genetics

    Volume 67, Issue 4, April 2005, Pages: 322–329, A Kataki, IP Gomatos, N Pararas, A Armakolas, D Panousopoulos, G Karantzikos, D Voros, G Zografos, C Markopoulos, E Leandros and MM Konstadoulakis

    Version of Record online : 27 JAN 2005, DOI: 10.1111/j.1399-0004.2004.00400.x

  20. You have free access to this content
    Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

    CA: A Cancer Journal for Clinicians

    Volume 61, Issue 1, January/February 2011, Pages: 31–49, Timothy A. Yap, Shahneen K. Sandhu, Craig P. Carden and Johann S. de Bono

    Version of Record online : 4 JAN 2011, DOI: 10.3322/caac.20095